Background Patients who experience a stroke or transient ischemic attack (TIA) are at high risk of recurrent stroke, but little is known about temporal trends in unselected populations. Reports of low adherence to recommended treatments indicate a need for enhanced secondary preventive follow-up to achieve the full potential of evidence-based treatments. In addition, socioeconomic factors have been associated with poor health outcomes in a variety of contexts. Therefore, it is important to assess the implementation and results of secondary prevention in different socioeconomic groups. Aims The aims of this thesis were to assess temporal trends in ischemic stroke recurrence and evaluate the implementation and results of a nurse-led, telephone-based follow-up program to improve blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) levels after stroke/TIA. Methods In study I, we collected baseline data for unique patients with an ischemic stroke event between 1998 and 2009 (n=196 765) from the Swedish Stroke Register (Riksstroke). Recurrent ischemic stroke events within 1 year were collected from the Swedish National Inpatient Register (IPR) and the cumulative incidence was compared between four time periods using the Kaplan-Meier survival analysis and the logrank test. Implementation (study II) and 1-year results (study III-IV) for the secondary preventive follow-up were studied in the NAILED (Nurse-based Age-independent Intervention to Limit Evolution of Disease) study. Between 1 Jan 2010 and 31 Dec 2013, the baseline characteristics of consecutive patients admitted to Östersund Hospital for acute stroke or TIA were collected prospectively (n=1776). Consenting patients in a condition permitting telephone-based follow-up were randomized to nurse-led, telephone-based follow-up or follow-up according to usual care. Follow-up was cunducted at 1 and 12 months after discharge and the intervention included BP and LDL-C measurements, titration of medication, and lifestyle counseling. In study II, we analyzed factors associated with non-participation in the randomized phase of the NAILED study, including association with education level. In addition, we compared the 1-year prognosis in terms of cumulative survival between participants and non-participants. In study III, we compared differences in BP and LDL-C levels between the intervention and control groups during the first year of follow-up and, in study IV, in relation to level of education (low, ≤10 years; high, >10 years). Results The cumulative 1-year incidence of recurrent ischemic stroke decreased from 15.0% to 12.0%. Among surviving stroke and TIA patients, 53.1% were included for randomization, 35.7% were excluded mainly due to physical or cognitive disability, and 11.2% declined participation in the randomized phase. A low level of education was independently associated with exclusion, as well as the patient’s decision to abstain from randomization. Excluded patients had a more than 12-times higher risk of death within 1 year than patients who were randomized. After 1 year of follow-up, the mean systolic BP, diastolic BP, and LDL-C levels were 3.3 mmHg (95% CI 0.3 to 6.3), 2.3 mmHg (95% CI 0.5 to 4.2), and 0.3 mmol/L (95% CI 0.1 to 0.4) lower in the intervention group than among controls. Among participants with values above the treatment goal at baseline, the differences in systolic BP and LDL-C levels were more pronounced (8.0 mmHg, 95% CI 4.0 to 12.1; 0.6 mmol/L, 95% CI 0.4 to 0.9). In the intervention group, participants with a low level of education achieved similar or larger improvements in BP and LDL-C than participants with a high level of education. In the control group, BP remained unaltered and the LDL-C levels increased among participants with a low level of education. Conclusion The 1-year risk of ischemic stroke recurrence decreased in Sweden between 1998 and 2010. Nurse-led, telephone-based secondary preventive follow-up is feasible in just over half of the survivors of acute stroke and TIA and achieve better than usual care in terms of BP and LDL-C levels, and equality in BP improvements across groups defined by education level. However, a large proportion of stroke survivors are in a general condition precluding this form of follow-up, and their prognosis in terms of 1-year survival is poor. Patients with a low education level are over-represented within this group and among patients declining randomization for secondary preventive follow-up.

A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine. / Current stroke imaging protocol at Barrow Neurological Institute calls for a noncontrast computed tomography (NCCT), a computed tomography angiography (CTA), and a computed tomography perfusion (CTP) at the time of presentation to the emergency department (ED), and follow up imaging includes magnetic resonance diffusion weighted imaging (MR‐DWI). This information is used to determine the appropriateness and safety of tissue plasminogen activator (tPA) administration. Previous studies have shown the risk for post‐tPA hemorrhagic conversion rises significantly as the size of the infarct core increases. Thus, it is of great importance to have an accurate method of measuring core infarct size in patients presenting with acute ischemic stroke. The purpose of our study is to determine if CTP correctly identifies the infarct core and if post‐tPA hemorrhagic conversion is related to the size of the infarct core and/or the accuracy of CTP in identifying the infarct core. The ultimate goal is to improve patient outcomes by decreasing the morbidity and mortality associated with tPA administration. This study is a retrospective chart review of all patients who presented to the ED during a one year period with signs and symptoms of acute ischemic stroke who then subsequently received tPA. Imaging was also reviewed, including the NCCT, CTA, CTP, and MRDWI for each patient. In this study, MR‐DWI is used as the gold standard for determining the presence or absence of an infarct core. CTP and MR‐DWI are in agreement of the presence of an infarct core in 7 patients, or 10 percent of the time. Similarly, CTP and MR‐DWI are in agreement of the absence of an infarct core in 31 patients, or 44 percent of the time. In the other 32 patients, CTP and MR‐DWI are in disagreement. The percent correlation between CTP and MR‐DWI was found to be 24 percent with a p‐value < 0.05. As for post‐tPA hemorrhagic conversion, 12 percent of patients had hemorrhagic conversion, and when the hemorrhage rate was compared to the size of the infarct core, the odds of post‐tPA hemorrhagic conversion were 56 times higher in the group of patients with infarct cores larger than one‐third of a vascular territory than in patients with smaller infarct cores with a p‐value < 0.001. Although no significant correlation was found between the accuracy of CTP data and the rate of post‐tPA hemorrhagic conversion, patients with concordant CTP and MR data had a 46% lower likelihood of post‐tPA hemorrhagic conversion than did patients with contradictory CTP and MR‐DWI data. Conclusion: Because patients with infarct cores larger than one‐third of a vascular territory are 56 times more likely to hemorrhage than patients with smaller infarct cores and CTP is less accurate than MR‐DWI in identifying the infarct core in patients presenting with acute ischemic stroke, CTP studies should not be part of the acute stroke imaging protocol. Another imaging modality, such as MR‐DWI, may be preferential in the setting of acute ischemic stroke to identify the infarct core.

A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine. / To analyze the roles of CCTA, MPI, and CC to formulate a sequential clinical algorithm to use in patients with chest pain, risk factors for CAD, and an abnormal EKG. The goals of the study are to streamline and refine workup, to decrease radiation exposure to patients, and to contain costs. 39 patients underwent CCTA, MPI, and CC within 30 months of each other. CCTA was used to categorize mild, moderate, or severe CAD. MPI used SSS, SDS, TID, and formal reading to define mild, moderate, or severe physiologic ischemia. CC and coronary intervention cine films were analyzed to define and treat anatomical CAD medically or by intervention. Results: There was strong correlation between CCTA, CC, and treatment type (p<0.0001). CCTA was able to stratify all patients with mild or severe ischemia to appropriate treatment groups, and to reduce the need for MPI. With moderate ischemia from CCTA, the additional use of MPI could have reduced the need for 16/18 (89%) patients who underwent CC to undergo further testing. No patients with mild or moderate CAD by CCTA, followed by mild to moderate physiologic ischemia by MPI, needed CC or intervention. 37/39 patients (95%) could have avoided one or more tests using our algorithm. CCTA followed by MPI may be used in symptomatic patients with risk factors for CAD and an abnormal EKG to stratify mild and moderate CAD, and to thereby avoid cardiac catheterization. Our algorithm could lead to savings in healthcare expenditures, save patients from unnecessary invasive procedures, decrease radiation exposure, and total cost.

Author: Bc. Alice Pernicová Title: Motor and cognitive consequences of hypoxic-ischemic damage Objectives: The aim of this diploma work was asses the impact of Enriched Environment on development of rats after hypoxic-ischemic damage. Methods: Experiment was performed in 30 Long Evans rats from breeding in Institute of Physiology, Academy of Sciences of the Czech Republic. All rats were operated for dissection of carotid. Than randomly were half of rats chosen for hypoxic-ischemic damage. Group with hypoxic-ischemic damage were divided into control and experimental group, same procedure was with rats without HIE. For one week were rats from experimental group in special Enriched Environment cage, than they were split into smaller cages with Enriched Environment. Rats from control groups were in normal cages without special equipment. After defined time were all rats tested by chosen test: Reaching test, Ladder rung walking test, Bar holding test, Rotarod test, Morris water maze test, Open filed test. For data analysis were used Microsoft Excel 365, Sigma plot. Results: Results of test showed, that Enriched Environment can positively enhance motoric and cognitive deficit in rat development with hypoxic-ischemic damage. But it is obvious, that Enriched Environment can positively enhance development...

Orientador: Silméia Garcia Zanati Bazan / Resumo: Introdução: O acidente vascular cerebral (AVC) isquêmico pode ser dividido etiologicamente em cinco tipos de acordo com a classificação TOAST e sua adequada investigação e caracterização pode auxiliar no manejo clínico e prevenção de novos eventos. O ecocardiograma transtorácico (ETT) é peça fundamental na investigação etiológica e cerca de um terço dos pacientes permanece sem definição adequada da etiologia ou são classificados como TOAST indeterminado. Objetivos: Avaliar se o percentual de indeterminação do TOAST diminui em função da realização do ecocardiograma transtorácico; avaliar se o prognóstico após o AVC isquêmico é pior entre pacientes que apresentam TOAST indeterminado e verificar a capacidade preditiva das variáveis ecocardiográficas sobre o prognóstico após AVC isquêmico. Metodologia: Coorte retrospectiva, na qual foram realizadas avaliações clínica, neurológica e ecocardiográfica durante internação por AVC e avaliação da mortalidade intra-hospitalar e da capacidade funcional no momento da alta hospitalar e após 90 dias. Foram realizados modelos de regressão linear múltipla e regressão logística múltipla ajustados pelos fatores confundidores. O nível de significância foi de 5%. Resultados: Foram incluídos 1100 pacientes, maioria do sexo masculino, 606 (55,09%), média de 68,1±13,3 anos de idade, em 977 (88,82%) pacientes foi realizado ETT e 448 (40,7%) tiveram classificação de TOAST indeterminado. Pacientes submetidos ao ecocardiograma transtorácico tiveram 3,1 v... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Background: Ischemic stroke can be divided etiologically into five types according to the TOAST classification, and its adequate investigation and characterization can aid in the clinical management and prevention of new events. Transthoracic echocardiography (TTE) plays a key role in etiological investigation, and about onethird of patients remain without adequate definition of the etiology or are classified as undetermined TOAST. Objectives: To evaluate if the percentage of indetermination of TOAST decreases according to the performance of the transthoracic echocardiography; to evaluate whether the prognosis after ischemic stroke is worse among patients with undetermined TOAST and to verify the predictive capacity of the echocardiographic variables on the prognosis after ischemic stroke. Methods: Retrospective cohort, in which clinical, neurological and echocardiographic evaluations were performed during stroke hospitalization and evaluation of in-hospital mortality and functional capacity at hospital discharge and after 90 days. Multiple linear regression and multiple logistic regression models were adjusted for confounding factors. The level of significance was 5%. Results: A total of 1100 patients were included, mostly male, 606 (55.09%), mean of 68.1 ± 13.3 years of age, and 977 (88.82%) patients were submitted to TTE and 448 (40.7%) had undetermined TOAST classification. Patients submitted to transthoracic echocardiography were 3.1 times less likely to have TOAST class... (Complete abstract click electronic access below) / Mestre

INTRODUÇÃO: Baseados em estudo que evidenciou menor área de infarto do miocárdio (IM) em ratos submetidos a treinamento físico (TF),na ausência de reperfusão; e na liberação de endorfinas que ocorre durante o TF, nossos objetivos são: demonstrar se não só TF, mas também opióides e isquemia/reperfusão (IR) intermitente são capazes de reduzir área de IM, na ausência de reperfusão; se TF e opióides exibem efeito sinérgico e se o mecanismo de redução da área de IM pelo TF envolve receptores opióides. MATERIAIS E MÉTODOS: Ratos Wistar machos (n=76) foram divididos em 7 grupos:1- controle;2- TF (esteira elétrica,1 hora/dia,5 vezes/semana,por 12 semanas), antes do IM; 3- morfina antes do IM; 4- morfina+TF; 5- grupo com 3 ciclos de IR antes do IM; 6- naloxone antes da morfina; 7- naloxone antes de cada dia de TF. Todos os ratos foram submetidos à mensuração da pressão diastólica final (PDF) e a IM através da oclusão da artéria descendente anterior. A eficácia do TF foi avaliada através do consumo de oxigênio (VO2) e da distância máxima percorrida. Os ratos foram sacrificados no 8o pós-IM e a área de IM mensurada por planimetria. RESULTADOS: Não houve diferença no peso inicial (p=0,94), mortalidade (p=0,99), e relação peso cardíaco/peso corporal (p=0,29) entre os grupos. Entretanto, houve aumento do deltaVO2 (VO2 pico - VO2repouso) (p=0,0001)e da distância máxima percorrida (p=0,0001), nos grupos treinados. A PDF aumentou no pós-IM, em todos os grupos (p=0,0001). Os grupos tratados tiveram menor área de IM (p=0,0001), com exceção dos grupos morfina + naloxone e TF+ naloxone sendo que não houve maior redução no grupo TF+morfina. Os grupos TF e TF+morfina apresentaram maior espessura do septo inter-ventricular, em relação ao grupo controle (p=0,0008). Já o grupo TF + naloxone não apresentou maior espessura do septo IV, em relação aos outros grupos. Também não houve diferença na densidade capilar (p=0,88). CONCLUSÃO: Não só TF, mas também morfina e IR reduzem a área de IM, na ausência de reperfusão, sendo que não há efeito sinérgico entre TF e morfina. Esta redução não ocorre através do aumento da densidade capilar. Além disto, a ação do TF sobre a área de IM provavelmente ocorre através do estímulo de receptores opióides, visto que seu bloqueio anulou o efeito cardioprotetor do TF / BACKGROUND AND OBJECTIVES: Studies have shown a decrease in infarcted area in rats submitted to exercise training (ET), in the absence of reperfusion. Based on that, we tested four hypotheses: 1- not only ET but also another stimulus that causes myocardial protection, like opioid infusion and brief periods of ischemia-reperfusion (IR) before irreversible left anterior descending (LAD) coronary occlusion could reduce infarct area, 2- ET plus opioid infusion could have additive effects in reducing infarct size, 3- blocking the opioid system we could lose the myocardial protection caused by ET, 4-myocardial protection given by different strategies could occur due to the increase in capillary density. METHODS: Male Wistar rats (n=76) were randomly assigned to 7 groups: control (n=11); ET (n=12); morphine infusion before myocardial infarction (MI) (n=14); ET plus morphine (n=11); naloxone (a non selective opioid receptor blocker) plus morphin (n=9); intermittent IR (n=12) before MI; naloxone before each ET session (n=7). All groups were submitted to MI by LAD ligation technique and to measurement of left ventricular end-diastolic pressure (LVEDP) before and 5 min after MI. ET was performed on a treadmill for 60 min, 5 times/week for 12 weeks at 60% peak oxygen (peak VO2). To evaluate the efficacy of ET, we tested the exercise capacity and the peak VO2 before and after experimental period. Seven days after MI induction, rats were killed and hearts were harvested. Infarct size was expressed by evaluation of necrotic area, expressed as a % of the risk region (total left ventricle area). RESULTS: There were no differences in initial weight, cardiac/animal weight or mortality among groups. Exercise training increased exercise capacity (p=0.0001) and delta VO2 (VO2 peak-VO2 rest) (p=0.0001). Inter-ventricular septum thickness was higher in the ET and ET plus morphine groups, compared to the control group (p=0.0008). The LVEDP increased in the post-MI period, for all groups (p=0.0001). All treatment groups but not morphine plus naloxone and ET plus naloxone showed a decrease in infarcted area (p=0.0001). There was no additional decrease in infarct size in the ET+ morphine group, comparing with each group alone . There was no difference in capillary density for all groups. CONCLUSION: Not only ET, but also morphine and IR decrease infarcted area, in the absence of reperfusion. There is no additional effect between ET and morphine. Moreover, this reduction is not due to an increase in capillary density. The effect of ET in decreasing infarct size might occur by opioid receptor stimulus

Introdução: O Acidente Vascular Cerebral (AVC) é a maior causa de morte no Brasil e um dos maiores responsáveis por incapacitação e invalidez. Existem informações insuficientes quanto aos principais fatores associados à ocorrência de óbito nos pacientes vítimas desta enfermidade. Alguns escores preditores foram desenvolvidos porém não foram validados em população brasileira até o momento. Uma das ações mais importantes na redução do ônus do AVC é o atendimento sistematizado destes pacientes de forma mulltidisciplinar em Unidades de AVC (UAVC) com potencial aumento do uso da terapia trombolítica, além da estratificação dos pacientes, possibilitando decisões terapêuticas mais precoces. Este estudo traz informações sobre o perfil epidemiológico dos pacientes admitidos na UAVC do Hospital Geral de Fortaleza (HGF), bem como identifica fatores preditores de mortalidade e incapacidade até a alta hospitalar e busca validar o Escore de Risco do Registro da Rede Canadense de AVC (IScore), possibilitando a utilização desta ferramenta na estratificação de risco de morte e incapacidade em uma população distinta daquela originalmente realizada. Objetivos: avaliar perfil clínico-epidemiológico dos pacientes e identificar fatores preditores independentes de mortalidade e incapacidade (primários); validar o iScore para morte ou incapacidade e desenvolver um escore na amostra para morte e incapacidade (secundários). Métodos: Foram selecionados pacientes consecutivos admitidos na Unidade de AVC do HGF entre novembro de 2009 até maio de 2012 com diagnóstico clínico de AVC isquêmico. Os dados foram coletados por equipe treinada e através de um formulário específico. Foi realizada análise univariada (método do quiquadrado) e análise multivariada (com regressão logística, stepwise forwardbackward) para descrição das características e identificação dos fatores associados ao desfecho. Teste de correlação de Pearson e curva ROC foram utilizados para medidas de correlação e desempenho dos escores prognósticos. Resultados: no período entre novembro de 2009 e maio de 2012 foram elegíveis 1433 pacientes, sendo 780 analisados. Houve predomíno do sexo masculino e a média de idade (± desvio padrão) foi de 66,1 anos (± 15,44). A forma de apresentação mais comum foi a fraqueza muscular (653 pacientes, 83,6%). O desfecho combinado ocorreu em 423 pacientes (45,8%) e 40 pacientes (5,1%) morreram. Foram identificados 8 fatores preditores independentes para o desfecho. O iScore apresentou bom desempenho, com AUC de 0,797 e Correlação de Pearson de 0,989. Conclusão: Pacientes com AVCi tem altas taxas de incapacidade ou morte até a alta de uma unidade de AVC. Medidas populacionais de informação tem potencial para reduzir a ocorrência dos desfechos. Foram identificados oito fatores preditores de mortalidade ou incapacidade. O iScore apresentou bom desempenho na amostra e pode ser utilizado com acurácia na população brasileira como ferramenta prognóstica. / Intoduction: Stroke is the leading cause of death and one of the most important disease associated with disability in Brazil. There is insufficient information about factors associated with death in stroke patients. Some death risk score has been developed, but none of them were applied in the Brazilian population yet. One of the most important actions to be done to reduce the burden of the stroke is the multidisciplinary assessment of the patients in stroke units (UAVC), with the potential to improve the thrombolytic therapy utilization and the early stratification of patients, allowing earlier treatment decisions. The present study, provides information on the epidemiological profile of patients admitted to the stroke unit in the Hospital Geral de Fortaleza (HGF), identifies predictors of in-hospital mortality and disability and seeks to validate the IScore, allowing the use of this tool to stratify the risk of death and disability in a population different from that which was originally derived. Objectives: to evaluate patient epidemiologic and clinical patterns and factors independently associated with death and disability at hospital discharge (primary objectives); to validate the iScore fitness to predict mortality and/or disability and to develop a new risk score to predict mortality and disability at discharge (secondary objectives). Methods: all consecutive patients admitted to the Hospital Geral de Fortaleza Stroke Unit since November 2009 until May 2012 were elegible. Data were collected by a trained team and by using a specific clinical research form. Univariable analysis (by chi-square test) followed by multivariable analysis (with logistic regression) were performed to identify and establish the variables associated with the outcome (death or disability at hospital discharge). Additionally, Pearson correlation test and ROC curve to measure the iScore correlation and discrimination ability were conducted. Results: a total of 1433 patients were selected and 781 considered eligible were included for the analysis. Male gender were more frequent; mean age was 66,1 (± 15,44). The most common clinical pattern at hospital arrival was \"weakness\" (653 pacientes, 83,6%). Outcome occurred in 423 patients (58,6%) and 40 patients (5,1%) had died. Eight factors were independently associated with outcome. The iScore had good performance, with AUC of 0,797 and Pearson Correlation Test of 0,985. Conclusion: Stroke patients have substantial rate of death or disability at hospital discharge. Populationbased strategies to inform about the signs and symptoms of stroke have potential to decrease this rate. Eight factors were identified as predictors of death or disability and might be used to support patient risk stratification. The iScore had a good performance in the sample and can be used with accuracy as a prognostic tool in Brazil.

L'aspirine est l'anti-plaquettaire le plus largement prescrit à la phase aiguë de l'accident vasculaire cérébral (AVC) ischémique. Cependant, la survenue de récidives, malgré cette prescription, est fréquente. La description de l'effet de l'aspirine sur l'activité plaquettaire durant cette phase n'a jamais été réalisée. Elle pourrait mettre en évidence une moindre réponse plaquettaire et aider à établir de nouvelles stratégies thérapeutiques. Cinquante patients, ont reçu par voie orale 300 mg d'aspirine, suite à un AVC ischémique. Ensuite, des prélèvements sanguins ont été réalisés : entre 2 et 3 heures (T1), entre 23 et 24 heures (T2) après la prise d'aspirine et, pour des patients déjà traités quotidiennement par une dose inférieure, avant la prise d'aspirine (T0). Les concentrations sériques de thromboxane (TX) B2 ont été mesurées, ainsi que les agrégations induites par l'acide arachidonique, par le collagène à la concentration de 2µg/L (Col2) et 20 µg/L (Col20). Afin de diminuer l'effet des variations de condition d'expérience, les résultats pour Col2 ont été rapportés à ceux pour Col20 (Col2/20). Tous les patients ont présenté une réponse à l?aspirine visible à T1 avec de plus, des concentrations de TXB2 abaissées en comparaison à T0. Il existe une récupération de l'activité plaquettaire à T2 comparée à T1, montrée par les concentrations de TXB2 et le rapport Col2/20. La dose orale de 300 mg d'aspirine, donnée à la phase aiguë de l'AVC, entraîne une inhibition plaquettaire, mais avec une récupération visible sur 24 heures. Pour les patients déjà traités quotidiennement par une dose inférieure, elle permet de compléter l'inhibition de la voie TXA2 dépendante / Aspirin is the most commonly used antiplatelet treatment during the acute phase of cerebral ischemic events. But, despite this protection, early ischemic recurrences are frequent, and considered as clinical failures of this therapy. We studied laboratory parameters of the first 300 mg oral dose of aspirin given, within 48 hours, after ischemic cerebral event. Fifty patients were included. For all patients, two blood sampling were performed, the first, during the third hour after aspirin intake (T1) and the second during the twenty-fourth hour (T2). For patients already treated with a daily dose of aspirin, a supplementary withdrawn was done before aspirin intake (T0). Platelet reactivity was studied on the basis of serum thromboxane (TX) B2 levels and light transmission aggregometry after stimulation of platelet-rich plasma by acid arachidonic and collagen 2µg/mL reported to results with collagen 20 µg/mL (ratio Col2/20). Inhibition of platelet activity was observed, at T1, for all patients. There is a significant increase of TXB2 values, and of relative values of the ratio Col2/20, at T2 as compared to T1. For already aspirin treated patients, there is a significant decrease of TXB2 levels at T1 as compared to T0. There is a platelet reactivity recovery within 24 hours, following the first 300 mg oral dose of aspirin, during the acute phase of a cerebral ischemic event, and demonstrated by TXB2 levels and ratio Col2/20. This fact would favour early ischemic recurrences. However, this dose is able to complete the inhibition of the TXA2 pathway for already aspirin treated patients

Made available in DSpace on 2016-03-22T17:27:31Z (GMT). No. of bitstreams: 1 Carla Vandame.pdf: 690431 bytes, checksum: dd9d45b9cf1994563baa2596d4e66e46 (MD5) Previous issue date: 2014-03-25 / The aim of this study was to investigate the prevalence of dyslipidemia by differentiation of lipid fractions and its association with cardiovascular risk. Was cross-sectional study of patients over 60 years of Basic Health Units in the urban area of Pelotas. We collected information from medical records of individuals who looked for the period January to July 2013 and were selected elderly patients with at least one of the following: total cholesterol (TC ) &#8805; 240mg/dL, LDL - cholesterol ( LDL - c ) &#8805; 150, triglycerides ( TG ) &#8805; 160 and / or HDL- cholesterol ( HDL-C ) < 40. Was investigated further age, sex, smoking, hypertension, diabettes mellittus and previous history of coronary artery disease. The most common lipid abnormality was hypertriglyceridemia - 40.5. Both CT and the LDL-C were higher among women, with values of 27.9 % and 32.3 % respectively, p < 0.001 compared to LDL-C, noting that even in those aged 60 to 69 years, with values of 29.6 % for total cholesterol and 31.9 % for LDL-C (p < 0.001 ). Women were more dyslipidemic than men who had HDL-C with values less than 40mg/dL / O objetivo deste estudo foi investigar as prevalências de dislipidemia por diferenciação das frações lipídicas e sua associação com risco cardiovascular. Foi um estudo transversal, sobre pacientes acima de 60 anos das Unidades Básicas de Saúde da zona urbana da cidade de Pelotas. Coletaram-se informações dos prontuários dos indivíduos que consultaram no período de janeiro a julho de 2013 e selecionaram-se idosos que apresentaram pelo menos uma das seguintes situações: colesterol total (CT) &#8805; 240mg/dL, LDL-colesterol (LDL-C) &#8805; 150, triglicerídeos (TG) &#8805; 160 e/ou HDL-colesterol (HDL-C)<40. Investigou-se ainda idade, sexo, tabagismo, hipertensão arterial sistêmica, diabettes mellittus e história prévia de doença arterial coronariana. A alteração lipídica mais frequente foi a hipertrigliceridemia - 40,5. Tanto CT quanto o LDL-C foram mais elevados entre as mulheres, com valores de 27,9% e 32,3% respectivamente, com p< 0,001 em relação a LDL-C, observando-se isto ainda naqueles, com idades entre 60 e 69 anos, sendo os valores de 29,6% para o colesterol total e 31,9% para o LDL-C (p<0,001). As mulheres mostraram-se mais dislipidêmicas do que os homens os quais apresentaram fração HDL-C com valores inferiores a 40mg/dL

Introdução: O aumento da tolerância do miocárdio isquêmico observado durante o segundo de dois testes de esforços seqüenciais, o fenômeno do pré-aquecimento, foi proposto como um modelo clínico do pré-condicionamento isquêmico. Bloqueadores dos canais de K-ATP dependentes, tais como as sulfoniluréias, podem induzir a perda do pré-condicionamento isquêmico, o qual poderia estar envolvido no aumento dos eventos cardiovasculares. A repaglinida é um agente hipoglicemiante oral, pertencente à família da meglitinida e supostamente dotada de menor efeito no pré-condicionamento isquêmico, ainda que o fármaco tenha seu principal mecanismo de ação nos canais de K-ATP dependentes. Objetivos e Métodos: O objetivo foi investigar os efeitos da repaglinida no fenômeno do pré-condicionamento isquêmico em pacientes diabéticos com doença coronariana estável. Foram estudados 42 pacientes diabéticos tipo 2, com angina estável e doença arterial documentada. Todos os pacientes tinham testes ergométricos positivos para isquemia. Na primeira fase do teste, a sulfoniluréia e os betabloqueadores foram suspensos por trinta dias e sete dias, respectivamente. Os pacientes foram submetidos a dois testes ergométricos seqüenciais, com intervalo de trinta minutos (testes 1 e 2). Na segunda fase, os pacientes receberam repaglinida por sete dias e mais dois testes ergométricos foram repetidos (testes 3 e 4). Resultados: Todos os pacientes alcançaram ST >1 mm na primeira fase (Teste 1 e 2). O tempo alcançado no teste 2 foi maior que aquele alcançado no teste 1 (4:44s. x 5:37s. p=0,001), como também foi maior a duração do exercício (6:15s x 6:29s. p=0,008), denotando pré-condicionamento isquêmico. Após o uso da repaglinida, nos testes 3 e 4, observou-se menor tempo alcançado para atingir isquemia no teste 4 (5:37s. x 4:58s. p=0,001). Observou-se, ainda, menor tempo de tolerância ao exercício na fase 2 (6:57s x 6:34s. p=0,007). Em relação ao surgimento de angina, não se constataram diferenças estatísticas entre as duas fases. Conclusão: Nos pacientes diabéticos com doença coronariana estável, a repaglinida bloqueou o pré-condicionamento isquêmico. / Background: The increase of tolerance to myocardial ischemia observed during the second of two sequential exercise tests, the warm-up phenomenon, has been proposed as a clinical model of ischemic preconditioning. Blockers of K-ATP channels, such as the Sulfonylurea drugs, can induce loss of ischemic preconditioning, what could be involved in an increase of cardiac events. Repaglinide is a hypoglycemic agent with supposedly lower influence on ischemic preconditioning, despite acting in K-ATP channels. Objectives and Methods: This study investigated the effects of repaglinide on the ischemic preconditioning in diabetic patients with CAD. There were 42 patients and inclusion criteria were positive treadmill test for myocardial ischemia. Sulphonylureas and beta-blocking agents were withdrawn 30 and 7 days respectively before phase 1 of the study. In this phase, the patients underwent two consecutive treadmill exercise tests at 30 minute intervals (test 1 and test 2). In phase 2 of the study, all patients received repaglinide 2 mg three times daily during 7 days before treadmill exercise test (test 3 and test 4). Results: All patients achieved 1.0 mm ST-segment depression during phase 1. The time achieved to ST depression during test 2 was greater than that during test 1 (4:44s vs. 5:37s. p=0.001) as well as the duration of the exercise (6:15s vs.6: 29s. p=0.008), suggesting a higher ischemic threshold. In phase 2 after repaglinide, all patients achieved 1 mm ST-segment depression. However, the time achieved to ST depression, as well as the duration of the exercise, was lower in test 4 comparing with test 3. There were no statistical differences regarding angina episodes in phase 1 or phase 2. Conclusions: In diabetic patients with stable coronary disease, the oral hypoglycemic agent repaglinide abolished the myocardial ischemic preconditioning.